Anti-IL-23 Antibody (Mirikizumab)
Catalog No.
F1287
Anti-IL-23 Antibody (Mirikizumab)
Featured Products
Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody that targets the p19 subunit of interleukin-23 (IL-23). Mirikizumab binds human and monkey IL-23 with high affinity, with Kd values of 21 pM and 55 pM, respectively. Mirikizumab modulates immune responses by inhibiting the binding of IL-23 to IL-23R and is expected to be used in the study of ulcerative colitis and Crohn's disease.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1884201-71-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
LY 3074828
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NPF7
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
IL-23
Please avoid freeze-thaw cycles.